We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Novelion Therapeutics Inc | NASDAQ:NVLN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.68 | 0.63 | 0.6677 | 0 | 01:00:00 |
British Columbia, Canada
|
|
000-17082
|
|
N/A
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
Exhibit No.
|
|
Description
|
99.1
|
|
Press Release, dated April 19, 2017.
|
|
Novelion Therapeutics Inc.
|
|
|
|
|
|
|
|
|
By:
|
/s/ Benjamin Harshbarger
|
|
Name:
|
Benjamin Harshbarger
|
|
Title:
|
General Counsel
|
Exhibit No.
|
|
Description
|
99.1
|
|
Press Release, dated April 19, 2017.
|
1 Year Novelion Therapeutics Chart |
1 Month Novelion Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions